glp-1 obesity drug updates Pipeline Update: August 2025 - Prime Therapeutics GLP-1 Targeted Peptide Weight Loss

Anesth Analg 118(5):938944

We have to be willing to listen to the patient and treat them with dignity, and respect, and let their voice be heard and elevated, and put ourselves aside, Stanford says

Herein, we have aimed to provide practical advice for HCPs considering a switch between GLP-1 receptor agonists, based on our clinical experience

Hypoglycemia risk Hypoglycemia, dangerously low blood sugar, is the most feared acute complication of insulin therapy

Among survey respondents, 76% provide GLP-1 drug coverage for diabetes, 27% provide coverage for weight loss, and 13% are considering covering for weight loss